1. Iceland Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Embla Medical hf.

Embla Medical hf.

OSSFF
Embla Medical hf.US flagOther OTC
4.15
USD
- -
- -
1.77BMarket Cap
Embla Medical hf.
OSSFF
(Other OTC)

Recent

price

4.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.79
0.88
0.89
0.97
1.13
1.09
1.19
1.32
1.44
1.62
1.49
1.7
1.72
1.87
2
2.18
2.06
Revenue per Share
0.08
0.07
0.09
0.09
0.13
0.12
0.12
0.13
0.19
0.16
0.01
0.15
0.1
0.14
0.16
0.2
0.17
Basic EPS, GAAP
0.07
0.07
0.1
0.11
0.15
0.09
0.09
0.13
0.09
0.15
0.16
0.17
0.08
0.09
0.18
0.23
0.2
Free Cash Flow per Basic Share
- -
- -
- -
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
- -
- -
- -
- -
- -
- -
Dividend per Share
0.75
0.81
0.9
0.98
1.03
1.14
1.18
1.24
1.16
1.27
1.27
1.41
1.54
1.68
1.79
1.98
1.89
Book Value per Share
-0.06
- -
0.06
0.01
0.03
0.13
0.06
0.09
-0.03
-0.03
-0.22
-0.18
-0.26
-0.12
-0.22
-0.11
-0.19
Tangible Book Value per Share
454
451
449
450
450
444
439
431
426
423
422
422
418
420
427
427
424
Basic Weighted Avg Shares
359
398
399
436
509
483
521
569
613
686
630
719
719
786
855
929
874
Sales/Revenue/Turnover
16.8
14.91
14.21
13.8
16.87
15.99
13.83
13.17
13.55
14.21
8.46
13.31
9.34
11.13
13.19
13.43
13.69
Operating Margin (%)
14
13
13
15
18
20
22
23
28
44
65
52
49
50
56
61
58
Depreciation Expense
35
34
38
40
59
51
51
58
80
66
6
64
43
58
68
83
73
Net Income, GAAP
25.87
26.1
25.78
25.93
23.6
25.33
25.46
16.12
17.64
23.7
37.73
24.22
23.08
22.64
23.85
22.51
23.48
Effective Tax Rate (%)
9.86
8.49
9.63
9.28
11.67
10.61
9.8
10.14
13.01
9.62
0.99
8.9
5.92
7.43
7.99
8.97
8.37
Profit Margin (%)
80
59
65
92
92
97
97
105
156
166
179
132
112
180
188
148
199
Working Capital
158
110
84
130
122
84
130
133
222
337
448
381
394
424
447
446
506
LT Debt
344
365
408
448
442
463
467
500
538
569
577
627
636
705
781
896
836
Total Equity
8.22
8.5
8.34
7.97
11.08
10.16
9.05
9.68
9.46
8.66
3.3
6.77
4.69
5.86
6.91
7
6.68
Return on Invested Capital (%)
8.89
7.88
8.66
7.78
10.52
9.07
8.4
8.83
11.64
8.52
1.09
6.73
4.64
6.25
6.98
7.38
6.77
Return on Capital (%)
10.95
9.56
9.95
9.54
13.14
10.61
9.97
10.96
15.57
12.82
1.16
11.32
6.85
8.66
9.3
10.34
9.54
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
53
61
59
LT Borrowings
329
339
361
LT Finance Leases
118
129
145
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
427
427
426
Market Capitalization
2,029
1,765
1,759

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
397
419
451
Cash, Cash Equivalents & STI
86
93
95
Accounts Receivable, Net
122
126
145
Inventories
143
154
157
Total Current Liabilities
209
241
253
Payables & Accruals
- -
- -
- -
ST Debt
53
61
59
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.91%
9.28%
14.74%
Free Cash Flow
16.87%
18.98%
30.51%
Net Income, GAAP
91.57%
194.52%
22.05%
Sales/Revenue/Turnover
- -
- -
8.63%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
200
217
214
225
855
2025
203
232
257
- -
929
2026
232
259
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.05
0.05
0.04
0.16
2025
0.03
0.05
0.06
- -
0.2
2026
0.03
0.07
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Health Logic Interactive Inc. (CHYPF)
Kelyniam Global, Inc. (KLYG)
Hamilton Thorne Ltd. (HTLZF)
Medinice S.A. (ICE.WA)
Getinge AB (publ) (GNGBY)
Olympus Corporation (OCPNF)
Business
Embla Medical hf. Embla Medical hf. (OSSFF), founded in 1971 and headquartered in Reykjavik, Iceland, is a leading global provider of innovative non-invasive orthopedic products and mobility solutions, operating through three main segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care; the company serves healthcare providers, rehabilitation specialists, orthopedic and prosthetic clinics, hospitals, and patients worldwide across the Americas, Europe, Middle East, Africa, Asia-Pacific, and beyond. In Prosthetics and Neuro Orthotics, it offers mechanical and bionic products including lower- and upper-limb prosthetics, microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints under brands such as Össur, Fior & Gentz, and College Park; Bracing and Supports provides devices for spinal, hip, knee, foot, ankle, and hand support as well as injury solutions for fractures, post-operative care, and ligament injuries; Patient Care delivers prosthetics and orthotics for neurological, gait, and musculoskeletal conditions through the ForMotion clinic network spanning multiple countries. Embla Medical hf., formerly known as Össur hf., changed its name in April 2024 and established itself as a unified entity incorporating leading brands Össur, Fior & Gentz, College Park, and ForMotion while advancing its Growth'27 strategy focused on patient reach, innovative solutions, and O&P value creation. Recent major developments include the early 2024 acquisition of Fior & Gentz, a developer of lower-limb neuro orthotic devices that expanded capabilities in chronic mobility challenges and contributed to 9% local currency sales growth; in July 2025, it signed an agreement to acquire a 51% majority stake in Streifeneder ortho.production GmbH, a German orthotics firm, via issuance of 2.8 million new shares valued at DKK 93 million to strengthen presence in the world's second-largest O&P market, enhance full-range offerings, and realize commercial synergies. As a subsidiary of William Demant Invest A/S and listed on Nasdaq Copenhagen, Embla Medical hf. emphasizes sustainable growth, reporting record 2024 sales of USD 855 million, 6% organic growth, and 20% EBITDA margin before special items, with operations supported by approximately 4,000 employees and over 2,100 patents.

Company News

APIChatGPT

  • seekingalpha.com

    Embla Medical hf. (OSSUY) Q1 2026 Earnings Call Transcript

  • seekingalpha.com

    Embla Medical hf. (OSSUY) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Embla Medical hf. (OSSUY) Q3 2025 Earnings Call Transcript